Why Did Hexo Stock Drop 10% on Tuesday?

Among cannabis stocks, Hexo (TSX:HEXO)(NASDAQ:HEXO) may top the list as biggest loser of 2021 and perhaps even 2022 with the way it’s going.

| More on:
Cannabis stocks have fallen.

There’s really only one word that can describe what happened to Hexo (TSX:HEXO)(NASDAQ:HEXO) on Tuesday: ouch. Shares fell to 52-week lows at $0.73 per share, down 10% at its lowest point.

What happened?

The small-cap stock continued to drop since announcing its losses late last year and even since appointing a new chief financial officer at the beginning of 2022. Hexo announced a loss of $116.9 million in the first quarter, along with a “new strategic plan” to reduce costs and create synergies.

That loss was a whopping 2,683% increase from the same time the year before, ahead of an overhaul of operations. It was the nail in the coffin, it seemed, since Chief Executive Officer Sebastien St-Louis and Chief Operating Officer Donald Courtney left Hexo in October.

So what?

While Hexo management has moved on, investors it seems have as well. Hexo right now looks like a loss at a time when investors aren’t looking for risk in their portfolio. The company didn’t maintain internal control over financial reporting, and that has to change.

To do this, the company will have to follow through with its plan to decrease costs as well as create acquisitions that could accelerate the company towards profitability. To do this quicker, Hexo management stated it will now focus on medical cannabis, expecting to create $50 million in synergies from recent acquisitions. This is an increase from $35 million previously announced.

Now what?

Let’s say Hexo checks all of these boxes. Is it still the cannabis company you want in your portfolio long term? Probably not. Supply and demand remain an incredible problem for cannabis companies. Meanwhile, the days of unprofitable marijuana companies should soon be over. Whether that means Hexo is purchased or collapses remains to be seen.

That being said, Hexo may also be undervalued given that it’s now at $0.73 per share. In fact, analysts still give it a consensus target price of $1.49, which is double today’s price. While that’s not that impressive, given that it traded at $14 at its 52-week high, it’s something.

Hexo stock announced its next earnings report would be Mar. 8, 2022. So, investors still have time to decide.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns HEXO Corp. The Motley Fool recommends HEXO Corp.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »